Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US team improves breast-implant procedure:

This article was originally published in Clinica

Executive Summary

A new antibiotic solution could help reduce or prevent breast implants from hardening, a common risk associated with cosmetic and reconstructive breast-implant surgery that might cause pain and interfere with mammography. Developed by researchers from the University of Texas Southwestern Medical Center in Dallas, the solution inhibits all bacterial growth from organisms commonly found around breast implants. Early results from an ongoing 125-patient trial of the product have shown positive results, according to the team, which reported its findings in the January issue of Plastic and Reconstructive Surgery.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT073034

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel